Search results for: “keytruda”
-
Blog
Immunotherapy: Oswald’s Partner in the Fight
In February 2017, Oswald became one of the first patients to receive pembrolizumab (Keytruda®) as first-line therapy…
-
Blog
Stomach Cancer Awareness Month: 2020 Immunotherapy Research Updates
This November for Stomach Cancer Awareness Month, we look at new research, new treatments, and how we’re…
-
Blog
Pancreatic Cancer Awareness Month: 2020 Immunotherapy Research Updates
This November for Pancreatic Cancer Awareness Month, we look at new research, new treatments, and how we’re…
-
Blog
Childhood Cancer Awareness Month: 2020 Immunotherapy Research Updates
This September for Childhood Cancer Awareness Month, we look at how we’re working toward a future immune…
-
Blog
ESMO20 Preview: Immunotherapy Updates at the ESMO Virtual Congress 2020
The latest results from a variety of immunotherapy trials will be revealed during the ESMO Virtual Congress…
-
Blog
Gynecologic Cancer Awareness Month: 2020 Immunotherapy Research Updates
This September for Gynecologic Cancer Awareness Month, we look at new FDA approvals, new research, and how…
-
Blog
How Immunotherapy is Making an Impact in Gynecologic Cancers
For Gynecologic Cancer Awareness Month, CRI spoke with Dr. Kunle Odunsi about immunotherapies for ovarian, cervical, and…
-
Blog
Prostate Cancer Awareness Month: 2020 Immunotherapy Research Updates
This September for Prostate Cancer Awareness Month, we look at new treatment combinations, new research, and how…
-
Blog
Drew Griffin’s Immunotherapy Story: Advocating For LGBTQ+ Cancer Patients
CRI ImmunoAdvocate Drew Griffin discusses advocacy strategies for LGBTQ+ cancer patients and allies.